GCA
LABU icon

Genesee Capital Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Genesee Capital Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-720
Closed -$54.9K – 121
2023
Q3 		$54.9K Buy
+720
New +$73.9K 0.04% 91

Other funds holding LABU

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Genesee Capital Advisors's LABU Position: Q4 2023 in Review

Genesee Capital Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2023, closing a stake of 720 shares — an estimated $54.9K sold.

Genesee Capital Advisors first reported a position in LABU in Q3 2023 and held it in 1 quarter. The position peaked at $54.9K in Q3 2023. 41 funds tracked by Wall St. Rank hold LABU as of Q4 2023.

  • Genesee Capital Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2023 after selling out during the quarter.
  • Genesee Capital Advisors sold 720 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2023, an estimated $54.9K.
  • Genesee Capital Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2023 and held it in 1 quarter.
  • Genesee Capital Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $54.9K in Q3 2023.
  • 41 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2023.

Based on Genesee Capital Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.